[go: up one dir, main page]

DE10342747A1 - Pharmazeutischer Wirkstoff gegen Melanome - Google Patents

Pharmazeutischer Wirkstoff gegen Melanome Download PDF

Info

Publication number
DE10342747A1
DE10342747A1 DE10342747A DE10342747A DE10342747A1 DE 10342747 A1 DE10342747 A1 DE 10342747A1 DE 10342747 A DE10342747 A DE 10342747A DE 10342747 A DE10342747 A DE 10342747A DE 10342747 A1 DE10342747 A1 DE 10342747A1
Authority
DE
Germany
Prior art keywords
pharmaceutical agent
agent against
against melanomas
melanomas
vipers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE10342747A
Other languages
English (en)
Inventor
Dirk Weickmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toximed GmbH
Original Assignee
Toximed GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toximed GmbH filed Critical Toximed GmbH
Priority to DE10342747A priority Critical patent/DE10342747A1/de
Priority to DE112004002332T priority patent/DE112004002332D2/de
Priority to PCT/DE2004/002058 priority patent/WO2005027942A1/de
Publication of DE10342747A1 publication Critical patent/DE10342747A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A61K35/58—Reptiles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Pharmazeutischer Wirkstoff zur Behandlung von Melanomen als Kombination von Substanzen, die aus biogenen Giften bzw. Mundsekreten bestimmter Arten von Vipern gewonnen werden.
DE10342747A 2003-09-16 2003-09-16 Pharmazeutischer Wirkstoff gegen Melanome Withdrawn DE10342747A1 (de)

Priority Applications (3)

Application Number Priority Date Filing Date Title
DE10342747A DE10342747A1 (de) 2003-09-16 2003-09-16 Pharmazeutischer Wirkstoff gegen Melanome
DE112004002332T DE112004002332D2 (de) 2003-09-16 2004-09-15 Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome
PCT/DE2004/002058 WO2005027942A1 (de) 2003-09-16 2004-09-15 Pharmazeutischer wirkstoff aus schlangengift gegen melanome

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10342747A DE10342747A1 (de) 2003-09-16 2003-09-16 Pharmazeutischer Wirkstoff gegen Melanome

Publications (1)

Publication Number Publication Date
DE10342747A1 true DE10342747A1 (de) 2005-04-28

Family

ID=34352861

Family Applications (2)

Application Number Title Priority Date Filing Date
DE10342747A Withdrawn DE10342747A1 (de) 2003-09-16 2003-09-16 Pharmazeutischer Wirkstoff gegen Melanome
DE112004002332T Expired - Fee Related DE112004002332D2 (de) 2003-09-16 2004-09-15 Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE112004002332T Expired - Fee Related DE112004002332D2 (de) 2003-09-16 2004-09-15 Pharmazeutischer Wirkstoff aus Schlangengift gegen Melanome

Country Status (2)

Country Link
DE (2) DE10342747A1 (de)
WO (1) WO2005027942A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GR1005321B (el) * 2005-04-27 2006-10-09 Χρηστος Καραμετας Η φαρμακευτικη δραση αιθανολικου εκχυλισματος ζωικης προελευσης σε κακοηθη και μη κακοηθη νοσηματα

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5164196A (en) * 1987-05-19 1992-11-17 Ventech Research, Inc. Crotoxin complex as cytotoxic agent
FR2623508B1 (fr) * 1987-11-20 1990-04-20 Commissariat Energie Atomique Proteine basique denommee phospholipase a2 isolee de venin de serpent de la famille des elapides et sa sequence en amino-acides, derives et fragments de ladite proteine, leur procede d'obtention, compositions therapeutiques et agents de diagnostic contenant ladite proteine et/ou ses derives et/ou ses fragments
CN1098293A (zh) * 1993-08-02 1995-02-08 程满温 蝎毒注射液及其制法和用法
US5565431A (en) * 1994-06-20 1996-10-15 Lipps; Binie V. Cancer cell inhibitors and method
US20030175277A1 (en) * 1996-09-11 2003-09-18 Elizabeth Shanahan-Prendergast Therapeutic formulations containing venom or venom anti-serum either alone or in combination for the therapeutic prophylaxis and therapy of neoplasms
CN1319612A (zh) * 2000-01-28 2001-10-31 上海博道基因技术有限公司 一种新的多肽——人蝎子短链毒素蛋白9和编码这种多肽的多核苷酸
CN1313099A (zh) * 2000-03-10 2001-09-19 史洪雨 蜈蛇大膏药
CN1352108A (zh) * 2000-11-06 2002-06-05 上海博德基因开发有限公司 一种新的多肽——人蝎子短链毒素蛋白18.59和编码这种多肽的多核苷酸
CN1424051A (zh) * 2002-11-29 2003-06-18 包春杰 一种注射用蝎毒冻干粉针剂

Also Published As

Publication number Publication date
DE112004002332D2 (de) 2006-08-10
WO2005027942A1 (de) 2005-03-31

Similar Documents

Publication Publication Date Title
ATE410430T1 (de) 2,3-dihydro-6-nitroimidazoä2,1- büoxazolverbindungen zur behandlung von tuberkulose
CY2014028I1 (el) Ενωσεις, φαρμακοτεχνικες μορφες και μεθοδοι θεραπειας ή αποτροπhς ροδοχρωμης ακμης
ATE512163T1 (de) Verabreichung von mitteln zur behandlung von entzündungen
ATE409176T1 (de) 1-phenylalkancarbonsäurederivate zur behandlung neurodegenerativer erkrankungen
DE602004020072D1 (de) 1,2,3,4-tetrasubstituiertes indol zur behandlung von atemwegserkrankungen
ATE339406T1 (de) Chinazoline verbindungen als heilmittel
ATE430154T1 (de) Amino-substituierte cyclohexan derivate zur behandlung bakterieller infektionen
BRPI0411743A (pt) método e composições para tratar doenças relacionadas a amilóides
TW200600087A (en) Methods and compositions for treating amyloid-related diseases
ATE319439T1 (de) Mittel zur behandlung von erkrankungen des tracheo-bronchialtraktes, insbesondere der copd
NO20071798L (no) Dermalt pafore formuleringer for behandling av hudsykdommer i dyr
DE602006005640D1 (de) 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
DE60326069D1 (de) 4-(heterocyclyl)-benzenesulfoximin verbindungen zur behandlung entzündlicher erkrankungenen
DE602006002608D1 (de) 4-phenyl-5-oxo-l,4,5,6,7,8-hexahydrochinolin-derivate als arzneimittel zur behandlung von unfruchtbarkeit
ATE457027T1 (de) Substituierte 1,4,8-triazaspiroä4.5 decan-2-on- verbindungen zur behandlung von fettsucht
WO2004073615A8 (en) Deazaflavin compounds and methods of use thereof
ATE457727T1 (de) Kombination aus pyrimidylaminobenzamid- verbindungen und imatinib zur behandlung oder verhinderung proliferativer erkrankungen
DE60308045D1 (de) Pflanzenextrakte aus argyrolobium roseum zur behandlung von diabetes
DE10342747A1 (de) Pharmazeutischer Wirkstoff gegen Melanome
UA87291C2 (ru) Пероральное пленкообразное лекарственное средство дезоксипеганина и способ его применения
DE602004029993D1 (de) Pharmazeutische zusammensetzung zur behandlung von drogenabhängigkeit
DE602004010172D1 (de) Pharmazeutische zusammensetzungen zur behandlung von nierenfunktionsstörungen
ATE545421T1 (de) Pharmazeutisches präparat zur behandlung von parasitären tropenkrankheiten enthaltend diminazen-di-aceturat
ATE412411T1 (de) Pmcol zur behandlung von prostatakrebs
EP1484066A4 (de) Mittel zur behandlung von infektionen

Legal Events

Date Code Title Description
8122 Nonbinding interest in granting licences declared
8143 Withdrawn due to claiming internal priority